From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...

To end the Latino HIV crisis, health programs must be developed, tailored and evolve to meet the health needs and preferences of our diverse Latino communities.

The National Agency for the Control of AIDS (NACA), on Wednesday, lamented that Ogun State, despite efforts to reduce the ...

Gilead Sciences (NASDAQ:GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention ...

A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it ...

Westport failed to provide a resident medication to treat advanced HIV for three weeks, resulting in "significant medication ...

Data from a phase Ia clinical trial of an oral, long-acting integrase inhibitor (GS-1720) in development for HIV demonstrated ...

In honor of World AIDs Day, the Coastal Health District (CHD) is offering three free HIV testing events in Savannah. At two ...

A new study from Tulane University finds that historical race-based lending practices are still impacting health today, ...

Joseph Kibler and his wife, Carey Cox, shared that they're expecting a baby who will be HIV-negative, despite Kibler's ...

A UNM researcher and assistant professor is breaking barriers in the health community for fellow Native Americans. Hailing ...

HIV is an infection that can be transmitted from one person to another through sexual activity, such as anal, oral, or ...